Pre-IPO Betta Pharmaceuticals - Insights on Products and Concerns
This article analyzed Betta Pharmaceutical in terms of its major products, pipeline, competitive landscape, and also include the concerns on the...
370 Views
Luye Pharma (2186.HK) - Could the Magic of Hillhouse Last Long?
This article analyzed Luye Pharma after the subscription agreement with Hillhouse in terms of the past performance, insights on recent changes, and...
371 Views
Pre-IPO Bio-Thera Solutions - Insights on Pipeline and the Competitive Landscape
This article summarized the insights on major products of Bio-Thera Solutions in the pipeline and related competitive landscape with other key...
462 Views
A Different Angle - RemeGen Vs Akeso (Insights on Valuation)
In this article, by comparing RemeGen and Akeso's pipelines from different aspects to provide referable and helpful insights about the valuation...
481 Views
Bio-Thera Solutions (百奥泰) A+H: Not an Attractive Pipeline
Bio-Thera is a China-based biopharmaceutical company. The company plans to raise at least USD 500m to list in Hong Kong.
340 Views